@Davisite (reply function not working). Does this mean the HREC governance applications can be made for various trials without waiting for the toxicology and safety pharmacology results which are expected by Q2 CY2024? So the trials can be conditionally approved by the HRECs pending the positive outcomes from the toxicology and safety pharmacology tests basis today’s announcement?
Ann: RC220 Peripheral Infusion Safety Confirmed, page-21
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.56 |
Change
0.010(0.65%) |
Mkt cap ! $269.1M | |||
| Open | High | Low | Value | Volume |
| $1.55 | $1.59 | $1.53 | $99.54K | 63.87K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 1274 | $1.56 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.58 | 6524 | 1 |
View Market Depth
| Last trade - 15.56pm 01/08/2024 (20 minute delay) ? |
| RAC (ASX) Chart |